In this article, Hervé Sibillat, general manager, ADM-SIO, discusses the important considerations in managing the natural variability of plant-based pharmaceutical ingredients.
In this article, Michael Adeogun, head of Life Sciences and Health at NPL examines how and where measurement can help government and industry grasp the opportunities the Strategy and Sector Deal offer.
All signs are that the life sciences and healthcare market is ripe for disruption, with ecommerce coming into its own in the sector. Scott Allison, president Life Sciences & Healthcare, DHL, lists five reasons as to why it is happening now.
Avoiding operational downtime is a major issue for all organisations, as the related disruption and financial consequences can prove catastrophic. Here, Tim Wynn-Jones suggests that organisations need to start taking it seriously.
In the first of the Tech Talk series, Novarum founder and BBI group head of mobile, Dr Neil Polwart, goes through his seven key tips that should be kept at front of mind when trying to implement a successful mHealth strategy.
The World Health Organisation (WHO) has released its first set of surveillance data on antibiotic resistance, revealing high levels of resistance to several serious bacterial infections globally.
About a year ago, Schott set out to elevate pharmaceutical glass quality to a new level with its perfeXion initiative. EPM sat down with Dr Patrick Markschläger, Schott Tubing, to discuss the impact of glass tubing on future packaging challenges.
As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages.
The latest report from data and analytics company, GlobalData, has revealed that the glaucoma market is expected to grow to $3.8 billion in 2026 as a result of the launch of pipeline products.
Administration of quadrivalent flu jabs should be on the agenda for the NHS as fourth flu strain, known as ‘Japanese flu’ is becoming most prevalent in Europe, according to data and analytics company, GlobalData.
Spotting the signs and symptoms of various infectious diseases can mean the difference between life and death. According to research in the journal Epidemiology and Infection, public awareness campaigns are vital in stopping infections spreading
The Brexit Health Alliance (BHA) has urged for regulatory arrangements to be made as a matter of urgency to prevent any potential risk to public health as a result of Brexit.
